Nanoparticle-based immunotherapeutics: from the properties of nanocores to the differential effects of administration routes.
暂无分享,去创建一个
[1] H. Goldschmidt,et al. The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients. , 2023, Cancer cell.
[2] B. Pelaz,et al. Nanosized metal–organic frameworks as unique platforms for bioapplications , 2023, Chemical communications.
[3] B. Pelaz,et al. Biomimetic cell-derived nanocarriers in cancer research , 2022, Journal of nanobiotechnology.
[4] Chaotao Hu,et al. Application of nanosonosensitizer materials in cancer sono-dynamic therapy , 2022, RSC advances.
[5] C. Agrati,et al. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave , 2022, Frontiers in Immunology.
[6] E. Topol,et al. Operation Nasal Vaccine—Lightning speed to counter COVID-19 , 2022, Science Immunology.
[7] Neil C. Dalvie,et al. Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity , 2022, Science Translational Medicine.
[8] Aaron J. Johnson,et al. Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination , 2022, Science Immunology.
[9] Chenjie Xu,et al. Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodulatory nanoparticles , 2022, Nature Communications.
[10] Yannan Yang,et al. Nanostructured Organosilica Nitric Oxide Donors Intrinsically Regulate Macrophage Polarization with Antitumor Effect. , 2022, ACS nano.
[11] L. Calzolai,et al. Characterization of nanoparticles-based vaccines for COVID-19 , 2022, Nature Nanotechnology.
[12] Yu Chen,et al. Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis , 2022, Nature Communications.
[13] Y. Oh,et al. In vivo fate and intracellular trafficking of vaccine delivery systems , 2022, Advanced Drug Delivery Reviews.
[14] H. Yang,et al. Artificial Assembled Macrophage Co-Deliver Black Phosphorus Quantum Dot and CDK4/6 Inhibitor for Colorectal Cancer Triple-Therapy. , 2022, ACS applied materials & interfaces.
[15] K. Willard-Gallo,et al. T follicular helper and B cell crosstalk in tertiary lymphoid structures and cancer immunotherapy , 2022, Nature Communications.
[16] Raghavendra Kikkeri,et al. The Shape of Nanostructures Encodes Immunomodulation of Carbohydrate Antigen and Vaccine Development. , 2022, ACS chemical biology.
[17] L. Bian,et al. The Effect of the Nanoparticle Shape on T Cell Activation. , 2022, Small.
[18] K. Roe. NK‐cell exhaustion, B‐cell exhaustion and T‐cell exhaustion—the differences and similarities , 2022, Immunology.
[19] Hongming Song,et al. IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation , 2022, Journal of Nanobiotechnology.
[20] Pei Cao,et al. Tailoring functional nanoparticles for oral vaccine delivery: Recent advances and future perspectives , 2022, Composites Part B: Engineering.
[21] L. Zitvogel,et al. Immunogenic cell stress and death , 2022, Nature Immunology.
[22] Zhigang Wang,et al. Near-Infrared II Nanoadjuvant-Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD-L1 Blockade to Enhance Antitumor Immunity. , 2022, Small.
[23] M. Netea,et al. Regulating trained immunity with nanomedicine , 2022, Nature Reviews Materials.
[24] Christian J. Konopka,et al. Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ. , 2022, ACS nano.
[25] Yining Zhu,et al. Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[26] N. Dantas,et al. CdSe magic-sized quantum dots attenuate reactive oxygen species generated by neutrophils and macrophages with implications in experimental arthritis. , 2022, Nanomedicine : nanotechnology, biology, and medicine.
[27] Z. Teng,et al. Flower-like mesoporous silica nanoparticles as an antigen delivery platform to promote systemic immune response. , 2022, Nanomedicine : nanotechnology, biology, and medicine.
[28] M. Diamond,et al. Innate immunity: the first line of defense against SARS-CoV-2 , 2022, Nature Immunology.
[29] Q. Lu,et al. A nano-innate immune system activator for cancer therapy in a 4T1 tumor-bearing mouse model , 2022, Journal of Nanobiotechnology.
[30] J. Gray,et al. Targeted Nanoparticle for Co-delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis. , 2022, Small.
[31] T. Hyeon,et al. Enhanced Chemodynamic Therapy by Cu-Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction. , 2022, ACS nano.
[32] Xiqun Jiang,et al. Enhancing Penetration Ability of Semiconducting Polymer Nanoparticles for Sonodynamic Therapy of Large Solid Tumor , 2022, Advanced science.
[33] Meiwan Chen,et al. Microfluidic Synthesis of Manganese-Alginate Nanogels with Self-Supplying H2O2 Capability for Synergistic Chemo/Chemodynamic Therapy and Boosting Anticancer Immunity , 2022, Chemical Engineering Journal.
[34] N. Kotov,et al. Enantiomer-dependent immunological response to chiral nanoparticles , 2022, Nature.
[35] Wei Zhang,et al. Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer , 2021, Journal of Nanobiotechnology.
[36] K. Dawson,et al. A Nanoscale Shape-Discovery Framework Supporting Systematic Investigations of Shape-Dependent Biological Effects and Immunomodulation , 2021, ACS nano.
[37] Weiqi Wang,et al. Insights on functionalized carbon nanotubes for cancer theranostics , 2021, Journal of Nanobiotechnology.
[38] N. Michael,et al. SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses , 2021, npj Vaccines.
[39] C. Roberts,et al. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency , 2021, Journal of Controlled Release.
[40] Ronnie H. Fang,et al. Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy , 2021, Leukemia.
[41] M. Buggert,et al. Human mucosal tissue-resident memory T cells in health and disease , 2021, Mucosal Immunology.
[42] Wangxiao He,et al. A Tumor-Targeting Metal-Organic Nanoparticle Constructed by Dynamic Combinatorial Chemistry toward Accurately Redressing Carcinogenic Wnt Cascade. , 2021, Small.
[43] Yuxin Guo,et al. Chemodynamic Therapy via Fenton and Fenton-Like Nanomaterials: Strategies and Recent Advances. , 2021, Small.
[44] H. Ghandehari,et al. Mechanisms of Immune Response to Inorganic Nanoparticles and Their Degradation Products. , 2021, Advanced drug delivery reviews.
[45] Conglian Yang,et al. Cell-Derived Biogenetic Gold Nanoparticles for Sensitizing Radiotherapy and Boosting Immune Response against Cancer. , 2021, Small.
[46] T. Pellegrino,et al. Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer. , 2021, Chemical Society reviews.
[47] Yan Yang,et al. Nanofactory for metabolic and chemodynamic therapy: pro-tumor lactate trapping and anti-tumor ROS transition , 2021, Journal of Nanobiotechnology.
[48] Min Wang,et al. The Dynamic Interactions between Nanoparticles and Macrophages Impact Their Fate in Brain Tumors. , 2021, Small.
[49] A. Samia,et al. Hyperthermia-mediated changes in the tumor immune microenvironment using iron oxide nanoparticles , 2021, Nanoscale advances.
[50] R. Rotomskis,et al. Uptake of Upconverting Nanoparticles by Breast Cancer Cells: Surface Coating versus the Protein Corona , 2021, ACS applied materials & interfaces.
[51] D. Zhao,et al. Imparting multi-functionality to covalent organic framework nanoparticles by the dual-ligand assistant encapsulation strategy , 2021, Nature Communications.
[52] R. Grose,et al. Tumour microenvironment 3D-modelling: simplicity to complexity and back again. , 2021, Trends in cancer.
[53] T. Randall,et al. Scent of a vaccine , 2021, Science.
[54] R. Oueslati,et al. Silver nanoparticles’ impact on the gene expression of the cytosolic adaptor MyD-88 and the interferon regulatory factor IRF in the gills and digestive gland of mytilus galloprovincialis , 2021, Drug and chemical toxicology.
[55] Cong Song,et al. Overcoming T Cell Exhaustion via Immune Checkpoint Modulation with a Dendrimer‐Based Hybrid Nanocomplex , 2021, Advanced healthcare materials.
[56] F. Voncken,et al. Contemporary radiotherapy: present and future , 2021, The Lancet.
[57] Qun Wang,et al. Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery. , 2021, Nanoscale.
[58] J. Conde,et al. Nanomedicine-based strategies to target and modulate the tumor microenvironment. , 2021, Trends in cancer.
[59] Xiangliang Yang,et al. Biomimetic sonodynamic therapy-nanovaccine integration platform potentiates Anti-PD-1 therapy in hypoxic tumors , 2021, Nano Today.
[60] P. Ritprajak,et al. Facile synthesis of magnetic silica-mannan nanocomposites for enhancement in internalization and immune response of dendritic cells , 2021 .
[61] T. Pellegrino,et al. Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity , 2021, Cancers.
[62] S. De Gendt,et al. Multicomponent Covalent Chemical Patterning of Graphene. , 2021, ACS nano.
[63] D. Ling,et al. Low-dose X-ray enhanced tumor accumulation of theranostic nanoparticles for high-performance bimodal imaging-guided photothermal therapy , 2021, Journal of Nanobiotechnology.
[64] Shaobing Zhou,et al. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy. , 2021, Nano letters.
[65] V. Puntes,et al. Gold nanoparticles (AuNPs) impair LPS-driven immune responses by promoting a tolerogenic-like dendritic cell phenotype with altered endosomal structures , 2021, Nanoscale.
[66] Teri W. Odom,et al. Nanoparticle Shape Determines Dynamics of Targeting Nanoconstructs on Cell Membranes. , 2021, Journal of the American Chemical Society.
[67] Q. Pankhurst,et al. Potential of Magnetic Hyperthermia to Stimulate Localized Immune Activation. , 2021, Small.
[68] D. Baker,et al. Quadrivalent influenza nanoparticle vaccines induce broad protection , 2021, Nature.
[69] R. Parton,et al. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics , 2021, Nature Nanotechnology.
[70] Y. Daali,et al. Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice. , 2021, ACS nano.
[71] Hong Yang,et al. Administration route governs the therapeutic efficacy, biodistribution and macrophage targeting of anti-inflammatory nanoparticles in the lung , 2021, Journal of Nanobiotechnology.
[72] Fernando Torres Andón,et al. Nano‐Oncologicals: A Tortoise Trail Reaching New Avenues , 2021, Advanced Functional Materials.
[73] M. Shawkey,et al. Unraveling the Structure and Function of Melanin through Synthesis. , 2021, Journal of the American Chemical Society.
[74] Z. Teng,et al. Bi-functional gold Nanocages enhance specific immunological responses of foot-and-mouth disease virus-like particles vaccine as a carrier and adjuvant. , 2021, Nanomedicine : nanotechnology, biology, and medicine.
[75] J. Boudon,et al. In vivo protein corona on nanoparticles: does the control of all material parameters orient the biological behavior? , 2021, Nanoscale advances.
[76] Jop de Vrieze. Pfizer's vaccine raises allergy concerns. , 2021, Science.
[77] Xiaolong Liu,et al. Localized NIR-II photo-immunotherapy through the combination of photothermal ablation and in situ generated interleukin-12 cytokine for efficiently eliminating primary and abscopal tumors. , 2020, Nanoscale.
[78] S. Sacanna,et al. Modulation of Immune Responses by Particle Size and Shape , 2021, Frontiers in Immunology.
[79] Y. Yao,et al. Effective and Safe Stimulation of Humoral and Cell-Mediated Immunity by Intradermal Immunization with a Cyclic Dinucleotide/Nanoparticle Combination Adjuvant , 2020, The Journal of Immunology.
[80] Cheng-Hsun Wu,et al. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer. , 2020, ACS applied materials & interfaces.
[81] Jun Lin,et al. Intelligent MoS2-CuO heterostructures with multiplexed imaging and remarkably enhanced antitumor efficacy via synergetic photothermal therapy/ chemodynamic therapy/ immunotherapy. , 2020, Biomaterials.
[82] Qiqing Zhang,et al. An Intelligent Biomimetic Nanoplatform for Holistic Treatment of Metastatic Triple-Negative Breast Cancer via Photothermal Ablation and Immune Remodeling. , 2020, ACS nano.
[83] K. Leong,et al. Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy. , 2020, Small.
[84] Paul C. Wang,et al. Proton-driven transformable nanovaccine for cancer immunotherapy , 2020, Nature Nanotechnology.
[85] Jun Xu,et al. Sonodynamic therapy with immune modulatable two-dimensional coordination nanosheets for enhanced anti-tumor immunotherapy , 2020, Nano Research.
[86] F. Ginhoux,et al. Intravenous Nanoparticle Vaccination Generates Stem-Like TCF1+ Neoantigen-Specific CD8+ T Cells , 2020, Nature immunology.
[87] Daniel W. Kulp,et al. A DNA-Launched Nanoparticle Vaccine Elicits CD8+ T-cell Immunity to Promote In Vivo Tumor Control , 2020, Cancer Immunology Research.
[88] S. Singamaneni,et al. Polydopamine-Mesoporous Silica Core-Shell Nanoparticles for Combined Photothermal-Immunotherapy. , 2020, ACS applied materials & interfaces.
[89] J. Collier,et al. Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health , 2020, Nature Nanotechnology.
[90] Chaoqun You,et al. A pH-activated autocatalytic nanoreactor for self-boosting Fenton-like chemodynamic therapy. , 2020, Nanoscale.
[91] S. Masters,et al. Constitutive immune mechanisms: mediators of host defence and immune regulation , 2020, Nature Reviews Immunology.
[92] A. Ito,et al. A nanoscale metal organic frameworks-based vaccine synergises with PD-1 blockade to potentiate anti-tumour immunity , 2020, Nature Communications.
[93] A. Singh,et al. Role of gold nanoparticles in advanced biomedical applications , 2020, Nanoscale advances.
[94] S. Mazzucchelli,et al. Indocyanine Green Nanoparticles: Are They Compelling for Cancer Treatment? , 2020, Frontiers in Chemistry.
[95] C. Brander,et al. TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells , 2020, Science Immunology.
[96] J. L. Jiménez Blanco,et al. Nanoparticle-Delivered HIV Peptides to Dendritic Cells a Promising Approach to Generate a Therapeutic Vaccine , 2020, Pharmaceutics.
[97] C. Pao,et al. Modulating Performance and Stability of Inorganic Lead-Free Perovskite Solar Cells via Lewis-pair mediation. , 2020, ACS applied materials & interfaces.
[98] K. Dawson,et al. Classification and biological identity of complex nano shapes , 2020, Communications Materials.
[99] Jun Xu,et al. Photosensitizer-Modified MnO2 Nanoparticles to Enhance Photodynamic Treatment of Abscesses and Boost Immune Protection for Treated Mice. , 2020, Small.
[100] V. Canzonieri,et al. Self-Therapeutic Nanomaterials for Cancer Therapy: A Review , 2020 .
[101] B. Espiña,et al. Magnetic Hyperthermia for Cancer Treatment: Main Parameters Affecting the Outcome of In Vitro and In Vivo Studies , 2020, Molecules.
[102] Xiaofang Zhong,et al. The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency , 2020, Science Advances.
[103] E. Richardson,et al. Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms , 2020, Cancer Gene Therapy.
[104] M. Lenardo,et al. A guide to cancer immunotherapy: from T cell basic science to clinical practice , 2020, Nature Reviews Immunology.
[105] Peifeng Li,et al. Reactive Oxygen Species-Related Nanoparticle Toxicity in the Biomedical Field , 2020, Nanoscale Research Letters.
[106] A. Loskog,et al. The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses , 2020, Frontiers in Immunology.
[107] Qijie Zhao,et al. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges , 2020, Journal of Nanobiotechnology.
[108] Xiangyang Shi,et al. Adoptive cellular immunotherapy of tumors via effective CpG delivery to dendritic cells using dendrimer-entrapped gold nanoparticles as a gene vector. , 2020, Journal of materials chemistry. B.
[109] Challenging paradigms in tumour drug delivery , 2020, Nature Materials.
[110] D. Zheng,et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy , 2020, Nature Communications.
[111] A. Chen,et al. Targeted tumour theranostics in mice via carbon quantum dots structurally mimicking large amino acids , 2020, Nature Biomedical Engineering.
[112] M. Jaafari,et al. Ex vivo-generated dendritic cell-based vaccines in melanoma: the role of nanoparticulate delivery systems. , 2020, Immunotherapy.
[113] J. M. Lanao,et al. Targeting of Hepatic Macrophages by Therapeutic Nanoparticles , 2020, Frontiers in Immunology.
[114] R. Wyatt,et al. Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity. , 2020, Cell reports.
[115] Feng Liu,et al. Quantum dot-pulsed dendritic cell vaccines plus macrophage polarization for amplified cancer immunotherapy. , 2020, Biomaterials.
[116] Daniel W. Kulp,et al. In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity , 2020, Advanced science.
[117] Xing-jie Liang,et al. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy , 2020, Theranostics.
[118] Thanh Loc Nguyen,et al. Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold. , 2020, Biomaterials.
[119] Yue Li,et al. V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation , 2020, Immunology.
[120] R. Jain,et al. A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.
[121] B. Fadeel,et al. Silver nanoparticles modulate lipopolysaccharide-triggered Toll-like receptor signaling in immune-competent human cell lines , 2020, Nanoscale advances.
[122] Qingsheng Wu,et al. Combined Magnetic Hyperthermia and Immune Therapy for Primary and Metastatic Tumor Treatments. , 2020, ACS nano.
[123] Peihong Wu,et al. Bisphosphonate Stabilized Calcium Phosphate Nanoparticles for Effective Delivery of Plasmid DNA to Macrophages. , 2020, ACS applied bio materials.
[124] C. Drake,et al. Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T cell immunity to tumor antigens , 2019, Nature Biotechnology.
[125] L. Hofbauer,et al. Increased pore size of scaffolds improves coating efficiency with sulfated hyaluronan and mineralization capacity of osteoblasts , 2019, Biomaterials research.
[126] S. Pokhrel,et al. Model‐Based Nanoengineered Pharmacokinetics of Iron‐Doped Copper Oxide for Nanomedical Applications , 2019, Angewandte Chemie.
[127] M. Walid Qoronfleh,et al. Therapeutic efficacy of nanoparticles and routes of administration , 2019, Biomaterials Research.
[128] James E Dahlman,et al. Mild Innate Immune Activation Overrides Efficient Nanoparticle‐Mediated RNA Delivery , 2019, Advanced materials.
[129] Zhuang Liu,et al. GSH‐Depleted PtCu3 Nanocages for Chemodynamic‐ Enhanced Sonodynamic Cancer Therapy , 2019, Advanced Functional Materials.
[130] Dong‐Hyun Kim,et al. Sequential MR Image-Guided Local Immune Checkpoint Blockade Cancer Immunotherapy Using Ferumoxytol Capped Ultralarge Pore Mesoporous Silica Carriers after Standard Chemotherapy. , 2019, Small.
[131] Adrian Berger,et al. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability , 2019, Nature Biomedical Engineering.
[132] James E. Crowe,et al. Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells. , 2019, ACS nano.
[133] Daniel G. Anderson,et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation , 2019, Nature Biotechnology.
[134] E. Wherry,et al. Defining ‘T cell exhaustion’ , 2019, Nature Reviews Immunology.
[135] Cheng Xu,et al. Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy. , 2019, ACS nano.
[136] B. Liu,et al. A tumor microenvironment responsive biodegradable CaCO3/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy , 2019, Theranostics.
[137] W. Chan,et al. Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity. , 2019, Nano letters.
[138] B. Liu,et al. Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer. , 2019, Acta biomaterialia.
[139] D. F. Barber,et al. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions , 2019, Front. Immunol..
[140] M. Penichet,et al. Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy , 2019, Nature Communications.
[141] Zhenzhong Zhang,et al. Cancer Cell Membrane-Biomimetic Nanoplatform for Enhanced Sonodynamic Therapy on Breast Cancer via Autophagy Regulation Strategy. , 2019, ACS applied materials & interfaces.
[142] Conglian Yang,et al. Intracellularly generated immunological gold nanoparticles for combinatorial photothermal therapy and immunotherapy against tumor. , 2019, Nano letters.
[143] D. F. Barber,et al. Magnetic targeting of adoptively transferred tumour-specific nanoparticle-loaded CD8+ T cells does not improve their tumour infiltration in a mouse model of cancer but promotes the retention of these cells in tumour-draining lymph nodes , 2019, Journal of Nanobiotechnology.
[144] P. Ágoston,et al. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. , 2019, The Lancet. Oncology.
[145] Gorka Orive,et al. Quantum Dots in Biomedical Applications , 2019, Acta biomaterialia.
[146] S. Sakaguchi,et al. Targeting Treg cells in cancer immunotherapy , 2019, European journal of immunology.
[147] Xing-jie Liang,et al. Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy. , 2019, Chem.
[148] M. Philip,et al. Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections. , 2019, Current opinion in immunology.
[149] Gry Persson,et al. The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer , 2019, Front. Immunol..
[150] Luodan Yu,et al. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice , 2019, Nature Communications.
[151] E. Wherry,et al. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.
[152] Tingting Wang,et al. Light-Enhanced O2-Evolving Nanoparticles Boost Photodynamic Therapy To Elicit Antitumor Immunity. , 2019, ACS applied materials & interfaces.
[153] Quentin Harmer,et al. Impact of Locally Administered Carboxydextran-Coated Super-Paramagnetic Iron Nanoparticles on Cellular Immune Function. , 2019, Small.
[154] J. Cyster,et al. B Cell Responses: Cell Interaction Dynamics and Decisions , 2019, Cell.
[155] David Baker,et al. Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus , 2019, Cell.
[156] Brian Ruffell,et al. Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.
[157] Feng Liu,et al. Self-Assembled Copper-Amino Acid Nanoparticles for in Situ Glutathione "AND" H2O2 Sequentially Triggered Chemodynamic Therapy. , 2018, Journal of the American Chemical Society.
[158] Seyed Moein Moghimi,et al. Immunoglobulin deposition on biomolecule corona determines complement opsonisation efficiency of preclinical and clinical nanoparticles , 2018, Nature Nanotechnology.
[159] W. Schwindt,et al. Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients , 2018, Journal of Neuro-Oncology.
[160] Yayi Hou,et al. Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression , 2018, Theranostics.
[161] Paul J. Hoover,et al. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma , 2018, Cell.
[162] J. Seo,et al. Cloaking nanoparticles with protein corona shield for targeted drug delivery , 2018, Nature Communications.
[163] C. Brinker,et al. Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics , 2018, Nature Communications.
[164] M. Fortin,et al. Gold Nanoparticles in Radiotherapy and Recent Progress in Nanobrachytherapy , 2018, Advanced healthcare materials.
[165] Sven Burgdorf,et al. Current Concepts of Antigen Cross-Presentation , 2018, Front. Immunol..
[166] Yifan Ma,et al. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases. , 2018, Biomaterials.
[167] Yongzhong Du,et al. Sustained release of anti‐PD‐1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[168] C. Hsieh,et al. Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy , 2018, Nature Nanotechnology.
[169] Tadaki Suzuki,et al. Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines , 2018, RSC advances.
[170] Lanxia Liu,et al. Photothermally Controlled MHC Class I Restricted CD8+ T‐Cell Responses Elicited by Hyaluronic Acid Decorated Gold Nanoparticles as a Vaccine for Cancer Immunotherapy , 2018, Advanced healthcare materials.
[171] Da-Peng Yang,et al. Combining Magnetic Resonance Imaging with Photothermal Therapy of CuS@BSA Nanoparticles for Cancer Theranostics , 2018 .
[172] K. Dawson,et al. Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure. , 2018, ACS nano.
[173] Yugang Wang,et al. Exploration of Antigen Induced CaCO3 Nanoparticles for Therapeutic Vaccine. , 2018, Small.
[174] V. Engelhard,et al. Immune Cell Infiltration and Tertiary Lymphoid Structures as Determinants of Antitumor Immunity , 2018, The Journal of Immunology.
[175] I. Amelio,et al. The hypoxic tumour microenvironment , 2018, Oncogenesis.
[176] Scott N. Mueller,et al. Migratory CD11b+ conventional dendritic cells induce T follicular helper cell–dependent antibody responses , 2017, Science Immunology.
[177] Gordon J. Freeman,et al. T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity , 2017, Nature Communications.
[178] Zhuang Liu,et al. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses , 2017, Nature Communications.
[179] Vincent M Rotello,et al. Effects of engineered nanoparticles on the innate immune system. , 2017, Seminars in immunology.
[180] Xiaoyuan Chen,et al. Suppressing Nanoparticle-Mononuclear Phagocyte System Interactions of Two-Dimensional Gold Nanorings for Improved Tumor Accumulation and Photothermal Ablation of Tumors. , 2017, ACS nano.
[181] R. Ganss,et al. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors , 2017, Nature Immunology.
[182] Liping Liu,et al. Encapsulation of Hydrophilic and Hydrophobic Peptides into Hollow Mesoporous Silica Nanoparticles for Enhancement of Antitumor Immune Response. , 2017, Small.
[183] M. Blosi,et al. Lipopolysaccharide Adsorbed to the Bio-Corona of TiO2 Nanoparticles Powerfully Activates Selected Pro-inflammatory Transduction Pathways , 2017, Front. Immunol..
[184] Laurence Zitvogel,et al. The immune contexture in cancer prognosis and treatment , 2017, Nature Reviews Clinical Oncology.
[185] Xiao Han,et al. Redox-Sensitive Nanoscale Coordination Polymers for Drug Delivery and Cancer Theranostics. , 2017, ACS applied materials & interfaces.
[186] Jianlin Shi,et al. Large-pore, silica particles with antibody-like, biorecognition sites for efficient protein separation. , 2017, Journal of materials chemistry. B.
[187] C. Duvall,et al. Zwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol. , 2017, ACS nano.
[188] Yanhui Qin,et al. CpG loaded MoS2 nanosheets as multifunctional agents for photothermal enhanced cancer immunotherapy. , 2017, Nanoscale.
[189] Seyed Moein Moghimi,et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. , 2017, Nature nanotechnology.
[190] Suk-Jo Kang,et al. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4. , 2017, Nano letters.
[191] Yulei Chang,et al. Precise Photodynamic Therapy of Cancer via Subcellular Dynamic Tracing of Dual-loaded Upconversion Nanophotosensitizers , 2017, Scientific Reports.
[192] T. Park,et al. Diverse Applications of Nanomedicine , 2017, ACS nano.
[193] M. Collado,et al. Advances toward More Efficient Targeted Delivery of Nanoparticles in Vivo: Understanding Interactions between Nanoparticles and Cells. , 2017, ACS nano.
[194] Yi Zhang,et al. Tumor-associated macrophages: from basic research to clinical application , 2017, Journal of Hematology & Oncology.
[195] R. Steinhardt,et al. Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery. , 2017, ACS biomaterials science & engineering.
[196] Bengt Fadeel,et al. Cytotoxic and Proinflammatory Effects of Metal-Based Nanoparticles on THP-1 Monocytes Characterized by Combined Proteomics Approaches. , 2017, Journal of proteome research.
[197] Xinyang Zhang,et al. Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species. , 2017, Nano letters.
[198] Delyan R. Hristov,et al. Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles. , 2017, ACS nano.
[199] S. Sakaguchi,et al. Regulatory T cells in cancer immunotherapy , 2016, Cell Research.
[200] Laura M Ensign,et al. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[201] Bradley Duncan,et al. Immunomodulatory effects of coated gold nanoparticles in LPS-stimulated in vitro and in vivo murine model systems. , 2016, Chem.
[202] David Baker,et al. Accurate design of megadalton-scale two-component icosahedral protein complexes , 2016, Science.
[203] F. Quintana,et al. Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2 , 2016, Science Signaling.
[204] D. Salah,et al. Singlet Oxygen Generation by Laser Irradiation of Gold Nanoparticles , 2016, The journal of physical chemistry. C, Nanomaterials and interfaces.
[205] M. Kundi,et al. Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine. , 2016, Vaccine.
[206] J. DeSimone,et al. Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells. , 2016, Nanomedicine : nanotechnology, biology, and medicine.
[207] Lisa M. Coussens,et al. The Basis of Oncoimmunology , 2016, Cell.
[208] Ting Liu,et al. Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor Hypoxia. , 2016, ACS nano.
[209] S. Kaech,et al. The multifaceted role of CD4+ T cells in CD8+ T cell memory , 2016, Nature Reviews Immunology.
[210] P. Chu,et al. Ultrasmall Black Phosphorus Quantum Dots: Synthesis and Use as Photothermal Agents. , 2015, Angewandte Chemie.
[211] Raimo Hartmann,et al. Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. , 2015, ACS nano.
[212] D. Drobne,et al. Nanoparticle interaction with the immune system / Interakcije nanodelcev z imunskim sistemom , 2015, Arhiv za higijenu rada i toksikologiju.
[213] Elizabeth A. Repasky,et al. Fever and the thermal regulation of immunity: the immune system feels the heat , 2015, Nature Reviews Immunology.
[214] Christoffer Åberg,et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. , 2015, Nature nanotechnology.
[215] Y. Yao,et al. Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[216] C. Mirkin,et al. Immunomodulatory spherical nucleic acids , 2015, Proceedings of the National Academy of Sciences.
[217] Scott G. Mitchell,et al. Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms. , 2015, ACS nano.
[218] K. Soo,et al. Nanoparticles in photodynamic therapy. , 2015, Chemical reviews.
[219] M. Edidin,et al. Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity , 2014, ACS nano.
[220] B. Bryan,et al. A genomics approach to identify susceptibilities of breast cancer cells to “fever-range” hyperthermia , 2014, BMC Cancer.
[221] K. Schäkel,et al. Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. , 2013, Cancer cell.
[222] C. Alexander,et al. Nanoparticle transport in epithelial cells: pathway switching through bioconjugation. , 2013, Small.
[223] I. Mellman,et al. Oncology meets immunology: the cancer-immunity cycle. , 2013, Immunity.
[224] Ick Chan Kwon,et al. Nanophotosensitizers toward advanced photodynamic therapy of Cancer. , 2013, Cancer letters.
[225] Takafumi Ninomiya,et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo. , 2013, ACS nano.
[226] I. Merfort,et al. Oxidative stress and inflammatory response to printer toner particles in human epithelial A549 lung cells. , 2013, Toxicology letters.
[227] V. Pokharkar,et al. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies. , 2013, International journal of pharmaceutics.
[228] Patrick Couvreur,et al. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. , 2012, Chemical reviews.
[229] I. Mellman,et al. Internalization and endosomal degradation of receptor-bound antigens regulate the efficiency of cross presentation by human dendritic cells. , 2012, Blood.
[230] R. Dummer,et al. Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+ T-cell responses in melanoma patients , 2012, European journal of immunology.
[231] O. Joffre,et al. Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.
[232] E. Wherry,et al. Progressive Loss of Memory T Cell Potential and Commitment to Exhaustion during Chronic Viral Infection , 2012, Journal of Virology.
[233] Dan Peer,et al. Nanoparticle hydrophobicity dictates immune response. , 2012, Journal of the American Chemical Society.
[234] P. Gao,et al. Synthesis of a novel kind of carbon nanoparticle with large mesopores and macropores and its application as an oral vaccine adjuvant. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[235] Young Keun Kim,et al. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. , 2011, Nature nanotechnology.
[236] Davoud Ahmadvand,et al. Material properties in complement activation. , 2011, Advanced drug delivery reviews.
[237] Bengt Fadeel,et al. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. , 2011, ACS nano.
[238] P. Kolattukudy,et al. Cerium Oxide Nanoparticles Inhibits Oxidative Stress and Nuclear Factor-κB Activation in H9c2 Cardiomyocytes Exposed to Cigarette Smoke Extract , 2011, Journal of Pharmacology and Experimental Therapeutics.
[239] H. Dai,et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. , 2011, Journal of the American Chemical Society.
[240] L. Zitvogel,et al. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress , 2011, Oncogene.
[241] R. Madan,et al. Sipuleucel-T: harbinger of a new age of therapeutics for prostate cancer , 2011, Expert review of vaccines.
[242] D. Roopenian,et al. Efficient Mucosal Delivery of Vaccine Using the FcRn-Mediated IgG Transfer Pathway , 2011, Nature biotechnology.
[243] Martin F. Bachmann,et al. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.
[244] Byung-Hoon Lee,et al. Genomics-based screening of differentially expressed genes in the brains of mice exposed to silver nanoparticles via inhalation , 2010 .
[245] Marina A Dobrovolskaia,et al. Nanoparticles and the immune system. , 2010, Endocrinology.
[246] Z. Marković,et al. Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60). , 2009, Biomaterials.
[247] S W Burchiel,et al. Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. , 2009, Nature nanotechnology.
[248] T. Lebien,et al. B lymphocytes: how they develop and function. , 2008, Blood.
[249] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[250] Oliver T. Bruns,et al. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. , 2007, Nano letters.
[251] Jan Holmgren,et al. Mucosal immunity and vaccines , 2005, Nature Medicine.
[252] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[253] E. Wherry,et al. Vaccines: Effector and memory T-cell differentiation: implications for vaccine development , 2002, Nature Reviews Immunology.
[254] S. Stolik,et al. Measurement of the penetration depths of red and near infrared light in human "ex vivo" tissues. , 2000, Journal of photochemistry and photobiology. B, Biology.
[255] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.